Q/C Technologies, Inc. (QCLS)
NCM · Computer Hardware
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
Peers in Computer Hardware
All in industry →Arista Networks, Inc.
Sandisk Corporation
Dell Technologies Inc.
Western Digital Corporation
Seagate Technology Holdings plc
Everpure, Inc.
HP Inc.
Super Micro Computer, Inc.
Logitech International S.A.
IonQ, Inc.
Recent press releases
Q/C Technologies, Inc. has not issued a press release in this window.
SEC filings
All filings →Q/C Technologies, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Q/C Technologies, Inc. has no reported insider trades in the last 90 days.